| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 4.88▲ | 4.87▲ | 4.86▲ | 4.87▲ | 6.70▼ |
| MA10 | 4.87▲ | 4.85▲ | 4.76▲ | 5.14▼ | 11.81▼ |
| MA20 | 4.86▲ | 4.75▲ | 4.84▲ | 5.40▼ | 12.95▼ |
| MA50 | 4.81▲ | 4.96▼ | 5.15▼ | 11.92▼ | 10.48▼ |
| MA100 | 4.87▲ | 5.18▼ | 5.01▼ | 12.87▼ | 10.95▼ |
| MA200 | 5.17▼ | 5.14▼ | 10.01▼ | 11.23▼ | 43.89▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.002▲ | 0.034▲ | 0.034▲ | 0.275▲ | -1.473▼ |
| RSI | 61.694▲ | 53.137▲ | 48.900▼ | 30.245▼ | 32.745▼ |
| STOCH | 70.903 | 84.088▲ | 86.359▲ | 35.373 | 22.643 |
| WILL %R | -31.250 | -6.250▲ | -15.730▲ | -53.974 | -95.350▼ |
| CCI | 175.139▲ | 86.627 | 79.554 | -52.411 | -119.185▼ |
|
Tuesday, January 20, 2026 09:16 AM
Pomerantz LLP is investigating claims on behalf of investors of Atara Biotherapeutics, Inc. (“Atara” or the “Company”) (NASDAQ: ATRA). Such investors are ...
|
|
Wednesday, January 14, 2026 05:28 AM
Atara Biotherapeutics (NASDAQ:ATRA) has developed Ebvallo (tabelecleucel), a novel second-line immunotherapy for Epstein–Barr virus–positive post-transplant lymphoproliferative disease (EBV-PTLD). The ...
|
|
Monday, January 12, 2026 03:06 AM
Atara Biotherapeutics Inc. (NASDAQ: ATRA) stock plummeted on Monday, with a session volume of 2.75 million compared to the average volume of 92,283 as per data from Benzinga Pro. The U.S. Food and ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 06/02/26 | 4.63 | 4.92 | 4.63 | 4.895 | 94,961 |
| 05/02/26 | 4.62 | 4.9656 | 4.50 | 4.51 | 132,718 |
| 04/02/26 | 5.07 | 5.18 | 4.7601 | 4.86 | 101,804 |
| 03/02/26 | 5.03 | 5.25 | 5.00 | 5.04 | 89,005 |
| 02/02/26 | 5.11 | 5.27 | 5.00 | 5.04 | 93,665 |
| 30/01/26 | 5.45 | 5.59 | 4.91 | 5.20 | 201,800 |
| 29/01/26 | 5.53 | 5.6911 | 5.40 | 5.51 | 174,711 |
| 28/01/26 | 5.60 | 5.71 | 5.35 | 5.50 | 191,724 |
| 27/01/26 | 5.20 | 5.68 | 5.20 | 5.56 | 292,211 |
| 26/01/26 | 5.20 | 5.4101 | 5.07 | 5.29 | 216,225 |
|
|
||||
|
|
||||
|
|